Back to Journals » Journal of Hepatocellular Carcinoma » Volume 9 » default

Journal of Hepatocellular Carcinoma

ISSN: 2253-5969


Archive: Volume 9, 2022

Repeated Measurement of FIB-4 to Predict Long-Term Risk of HCC Development Up to 10 Years After SVR

Zou Y, Yue M, Jia L, Wang Y, Chen H, Wang Y, Zhang M, Feng Y, Yu R, Yang S, Huang P

Journal of Hepatocellular Carcinoma 2022, 9:1433-1443

Published Date: 30 December 2022

The Clinical Relevance and Immune Correlation of SLC10 Family Genes in Liver Cancer

Tian S, Li J, Xiang J, Peng P

Journal of Hepatocellular Carcinoma 2022, 9:1415-1431

Published Date: 30 December 2022

Development and Validation of Prognostic Nomograms for Hepatocellular Carcinoma After Hepatectomy Based on Inflammatory Markers

Hu Z, Yuan Y, Hu Z, Liu Q, Fu Y, Hou J, Sun X, Li S, Duan W, Chen M

Journal of Hepatocellular Carcinoma 2022, 9:1403-1413

Published Date: 29 December 2022

Boron Neutron Capture Therapy Eliminates Radioresistant Liver Cancer Cells by Targeting DNA Damage and Repair Responses

Huang CY, Lai ZY, Hsu TJ, Chou FI, Liu HM, Chuang YJ

Journal of Hepatocellular Carcinoma 2022, 9:1385-1401

Published Date: 29 December 2022

Sulfatase 2 Along with Syndecan 1 and Glypican 3 Serum Levels are Associated with a Prognostic Value in Patients with Alcoholic Cirrhosis-Related Advanced Hepatocellular Carcinoma

Mouhoubi N, Bamba-Funck J, Sutton A, Blaise L, Seror O, Ganne-Carrié N, Ziol M, N'Kontchou G, Charnaux N, Nahon P, Nault JC, Guyot E

Journal of Hepatocellular Carcinoma 2022, 9:1369-1383

Published Date: 28 December 2022

Hepatectomy After Conversion Therapy for Initially Unresectable HCC: What is the Difference?

Luo L, He Y, Zhu G, Xiao Y, Song S, Ge X, Wang T, Xie J, Deng W, Hu Z, Shan R

Journal of Hepatocellular Carcinoma 2022, 9:1353-1368

Published Date: 22 December 2022

Nrf2-siRNA Enhanced the Anti-Tumor Effects of As2O3 in 5-Fluorouracil-Resistant Hepatocellular Carcinoma by Inhibiting HIF-1α/HSP70 Signaling

Duan X, Xu W, Li H, Wang M, Wang W, Lu H, Zhang Y, Han X

Journal of Hepatocellular Carcinoma 2022, 9:1341-1352

Published Date: 21 December 2022

ARFIP2 Regulates EMT and Autophagy in Hepatocellular Carcinoma in Part Through the PI3K/Akt Signalling Pathway

Huang K, Lin Y, Wang K, Shen J, Wei D

Journal of Hepatocellular Carcinoma 2022, 9:1323-1339

Published Date: 20 December 2022

Advanced Hepatocellular Carcinoma in Adults Without Cirrhosis: A Single-Institution Retrospective Review

Altshuler E, Richhart R, Aryan M, King W, Pan K, Mathavan A, Mathavan A, Rodriguez D, Paudel B, Northern N, Ramnaraign B, Sahin I, Fabregas, JC

Journal of Hepatocellular Carcinoma 2022, 9:1299-1307

Published Date: 19 December 2022

Antitumor Effects and Mechanisms of Metabolic Syndrome Medications on Hepatocellular Carcinoma

Oura K, Morishita A, Tani J, Masaki T

Journal of Hepatocellular Carcinoma 2022, 9:1279-1298

Published Date: 14 December 2022

Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research

Fornari F, Giovannini C, Piscaglia F, Gramantieri L

Journal of Hepatocellular Carcinoma 2022, 9:1263-1278

Published Date: 8 December 2022

The Abnormal Proliferation of Hepatocytes is Associated with MC-LR and C-Terminal Truncated HBX Synergistic Disturbance of the Redox Balance

Cai DM, Mei FB, Zhang CJ, An SC, Lv RB, Ren GH, Xiao CC, Long L, Huang TR, Deng W

Journal of Hepatocellular Carcinoma 2022, 9:1229-1246

Published Date: 5 December 2022

Systemic Therapy in Advanced Hepatocellular Carcinoma: Patient Selection and Key Considerations

Storandt MH, Mahipal A, Tella SH, Kommalapati A, Jin Z

Journal of Hepatocellular Carcinoma 2022, 9:1187-1200

Published Date: 29 November 2022

Efficacy and Safety of TKI Plus PD-1 Inhibitors in Elderly uHCC Patients: A Retrospective Study

Chen B, Lei J, Zhao H, Dong J, Zeng Z, Li Y, Yu L, Zhou L, Jia A, Lu Y, Cheng J

Journal of Hepatocellular Carcinoma 2022, 9:1171-1185

Published Date: 8 November 2022

Understanding the Immunoenvironment of Primary Liver Cancer: A Histopathology Perspective

Chung A, Nasralla D, Quaglia A

Journal of Hepatocellular Carcinoma 2022, 9:1149-1169

Published Date: 2 November 2022

Prognostic Value of Red Blood Cell Distribution Width (RDW) in the Recurrence of Hepatocellular Carcinoma Following Curative Resection

Golriz M, Ramouz A, Ali-Hasan-Al-Saegh S, Shafiei S, Aminizadeh E, Hammad A, Mieth M, Rupp C, Springfeld C, Hoffmann K, Büchler M, Mehrabi A

Journal of Hepatocellular Carcinoma 2022, 9:1137-1147

Published Date: 31 October 2022

Tumor Microenvironment in Hepatocellular Carcinoma: Key Players for Immunotherapy

Feng H, Zhuo Y, Zhang X, Li Y, Li Y, Duan X, Shi J, Xu C, Gao Y, Yu Z

Journal of Hepatocellular Carcinoma 2022, 9:1109-1125

Published Date: 26 October 2022

Thrombotic Thrombocytopenic Purpura After Radiofrequency Ablation of Hepatocellular Carcinoma: A Case Report

Chen R, Zhao Y, Umba Mabombo P, Hu H, Zhou X

Journal of Hepatocellular Carcinoma 2022, 9:1105-1108

Published Date: 26 October 2022

Incidence of Hepatocellular Carcinoma and Decompensated Liver Cirrhosis and Prognostic Accuracy of the PAGE-B HCC Risk Score in a Low Endemic Hepatitis B Virus Infected Population

Bollerup S, Engsig F, Hallager S, Mocroft A, Roege BT, Christensen PB, Laursen AL, Krarup H, Clausen MR, Thielsen P, Madsen LG, Noerregaard L, Barfod TS, Balslev U, Tarp B, Hansen JB, Mygind LH, Gerstoft J, Weis N

Journal of Hepatocellular Carcinoma 2022, 9:1093-1104

Published Date: 18 October 2022

Delayed Hepatocellular Carcinoma Recurrence After Liver Transplantation: Comprehensive Clinical Characterization of Case Series

Wong TH, Ho CM, Hsu HH, Wu YM, Ho MC, Lee PH, Hu RH

Journal of Hepatocellular Carcinoma 2022, 9:1081-1091

Published Date: 17 October 2022

Serum IGF-1 Scores and Clinical Outcomes in the Phase III IMbrave150 Study of Atezolizumab Plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma

Kaseb AO, Guan Y, Gok Yavuz B, Abbas AR, Lu S, Hasanov E, Toh HC, Verret W, Wang Y

Journal of Hepatocellular Carcinoma 2022, 9:1065-1079

Published Date: 11 October 2022

Assessment and Monitoring of Response to Systemic Treatment in Advanced Hepatocellular Carcinoma: Current Insights

Cammarota A, Zanuso V, Pressiani T, Personeni N, Rimassa L

Journal of Hepatocellular Carcinoma 2022, 9:1011-1027

Published Date: 14 September 2022

Hepatic Arterial Infusion Chemotherapy as a Timing Strategy for Conversion Surgery to Treat Hepatocellular Carcinoma: A Single-Center Real-World Study

Wang J, Zheng Z, Wu T, Li W, Wang J, Pan Y, Peng W, Hu D, Hou J, Xu L, Zhang Y, Chen M, Zhang R, Zhou Z

Journal of Hepatocellular Carcinoma 2022, 9:999-1010

Published Date: 14 September 2022

Impaired Autophagy Response in Hepatocellular Carcinomas Enriches Glypican-3 in Exosomes, Not in the Microvesicles

Koksal AR, Thevenot P, Aydin Y, Nunez K, Sandow T, Widmer K, Nayak L, Scott J, Delk M, Moehlen MW, Cohen AJ, Dash S

Journal of Hepatocellular Carcinoma 2022, 9:959-972

Published Date: 7 September 2022

Recurrent Hepatocellular Carcinoma: Patterns, Detection, Staging and Treatment

Papaconstantinou D, Tsilimigras DI, Pawlik TM

Journal of Hepatocellular Carcinoma 2022, 9:947-957

Published Date: 3 September 2022

Neoadjuvant Therapy for Hepatocellular Carcinoma

Yin Z, Chen D, Liang S, Li X

Journal of Hepatocellular Carcinoma 2022, 9:929-946

Published Date: 31 August 2022

The Prognostic Value of Baseline Clinical and Radiologic Imaging Features in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab

Awiwi MO, Elsayes KM, Mohamed YI, Altameemi L, Gjoni M, Irshad OM, Sayed Ahmed A, Kaseb AO, Salem U

Journal of Hepatocellular Carcinoma 2022, 9:913-927

Published Date: 30 August 2022

A Novel Nomogram for Prediction of Post-Hepatectomy Liver Failure in Patients with Resectable Hepatocellular Carcinoma: A Multicenter Study

Wang J, Zhang Z, Shang D, Liao Y, Yu P, Li J, Chen S, Liu D, Miao H, Li S, Zhang B, Huang A, Liu H, Zhang Y, Qi X

Journal of Hepatocellular Carcinoma 2022, 9:901-912

Published Date: 27 August 2022

Identification and Validation in a Novel Classification of Helicase Patterns for the Prediction of Tumor Proliferation and Prognosis

Yin Y, Xu ZY, Liu YJ, Huang W, Zhang Q, Li JP, Zou X

Journal of Hepatocellular Carcinoma 2022, 9:885-900

Published Date: 27 August 2022

Pathogenesis from Inflammation to Cancer in NASH-Derived HCC

Yu S, Wang J, Zheng H, Wang R, Johnson N, Li T, Li P, Lin J, Li Y, Yan J, Zhang Y, Zhu Z, Ding X

Journal of Hepatocellular Carcinoma 2022, 9:855-867

Published Date: 26 August 2022

Experimental Validation of Novel Glypican 3 Exosomes for the Detection of Hepatocellular Carcinoma in Liver Cirrhosis [Corrigendum]

Aydin Y, Koksal AR, Thevenot P, Chava S, Heidari Z, Lin D, Sandow T, Moroz K, Parsi MA, Scott J, Cohen A, Dash S

Journal of Hepatocellular Carcinoma 2022, 9:853-854

Published Date: 29 August 2022

Extending Surgical Resection for Hepatocellular Carcinoma Beyond Barcelona Clinic for Liver Cancer (BCLC) Stage A: A Novel Application of the Modified BCLC Staging System

Wee IJY, Moe FNN, Sultana R, Ang RWT, Quek PPS, Goh BKP, Chan CY, Cheow PC, Chung AYF, Jeyaraj PR, Koh YX, Mack POP, Ooi LLPJ, Tan EK, Teo JY, Kam JH, Chua JSS, Ng AWY, Goh JSQ, Chow PKH

Journal of Hepatocellular Carcinoma 2022, 9:839-851

Published Date: 17 August 2022

Disruption of Growth Hormone Receptor Signaling Abrogates Hepatocellular Carcinoma Development

Haque A, Sahu V, Lombardo JL, Xiao L, George B, Wolff RA, Morris JS, Rashid A, Kopchick JJ, Kaseb AO, Amin HM

Journal of Hepatocellular Carcinoma 2022, 9:823-837

Published Date: 15 August 2022

Safety and Efficacy of Drug-Eluting Beads Trans-Arterial Chemoembolization for Hepatocellular Carcinoma in Taiwan (SERENADE-T)

Liu YS, Chang PY, Liang PC, Ou MC, Hwang JI, Chen CH

Journal of Hepatocellular Carcinoma 2022, 9:811-821

Published Date: 15 August 2022

Predictive Value of Preoperative Serum AFP, CEA, and CA19-9 Levels in Patients with Single Small Hepatocellular Carcinoma: Retrospective Study

Gan L, Ren S, Lang M, Li G, Fang F, Chen L, Liu Y, Han R, Zhu K, Song T

Journal of Hepatocellular Carcinoma 2022, 9:799-810

Published Date: 13 August 2022

Effect of Transarterial Chemoembolization Plus Percutaneous Ethanol Injection or Radiofrequency Ablation for Liver Tumors

Chen L, Zhang W, Sun T, Ren Y, Sun B, Zhu L, Zhao H, Zheng C

Journal of Hepatocellular Carcinoma 2022, 9:783-797

Published Date: 12 August 2022

Vitamin B6 Metabolic Pathway is Involved in the Pathogenesis of Liver Diseases via Multi-Omics Analysis

Mei M, Liu D, Tang X, You Y, Peng B, He X, Huang J

Journal of Hepatocellular Carcinoma 2022, 9:729-750

Published Date: 11 August 2022

Nomogram for the Preoperative Prediction of the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma

Shan Y, Yu X, Yang Y, Sun J, Wu S, Mao S, Lu C

Journal of Hepatocellular Carcinoma 2022, 9:717-728

Published Date: 10 August 2022

Does HCC Etiology Impact the Efficacy of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma? An Asian Liver Radiation Therapy Group Study

Kim N, Cheng JCH, Ohri N, Huang WY, Kimura T, Zeng ZC, Lee VHF, Kay CS, Seong J

Journal of Hepatocellular Carcinoma 2022, 9:707-715

Published Date: 6 August 2022

Transarterial Chemoebolization in Hepatocellular Carcinoma: A Binational Japanese-German Study

Auer TA, Sofue K, Ueshima E, Rauer N, Yamaguchi T, Gebauer B, Hamm B, Murakami T, Althoff CE

Journal of Hepatocellular Carcinoma 2022, 9:695-705

Published Date: 1 August 2022

A Machine Learning Model Based on Health Records for Predicting Recurrence After Microwave Ablation of Hepatocellular Carcinoma

An C, Yang H, Yu X, Han Z, Cheng Z, Liu F, Dou J, Li B, Li Y, Li Y, Yu J, Liang P

Journal of Hepatocellular Carcinoma 2022, 9:671-684

Published Date: 28 July 2022

Macrotrabecular-Massive Hepatocellular Carcinoma: Light and Shadow in Current Knowledge

Sessa A, Mulé S, Brustia R, Regnault H, Galletto Pregliasco A, Rhaiem R, Leroy V, Sommacale D, Luciani A, Calderaro J, Amaddeo G

Journal of Hepatocellular Carcinoma 2022, 9:661-670

Published Date: 27 July 2022

Histological Severity of Cirrhosis Influences Surgical Outcomes of Hepatocellular Carcinoma After Curative Hepatectomy

Liang BY, Gu J, Xiong M, Zhang EL, Zhang ZY, Lau WY, Wang SF, Guan Y, Chen XP, Huang ZY

Journal of Hepatocellular Carcinoma 2022, 9:633-647

Published Date: 23 July 2022

Effects of Early TACE Refractoriness on Survival in Patients with Hepatocellular Carcinoma: A Real-World Study

Yang C, Luo YG, Yang HC, Yao ZH, Li X

Journal of Hepatocellular Carcinoma 2022, 9:621-631

Published Date: 21 July 2022

Natural Killer Group 2D Receptor and B1a Cells Crosstalk in Post-Hepatitis C Virus Infection Hepatocellular Carcinoma and Cirrhosis

Hammad R, Eldosoky MA, Mosaad AM, El-Nasser AM, Kotb FM, Elshennawy SI, Eldesoky NAR, Selim MA, Naguib GG, Ahmed OA, Alboraie M, Aglan RB

Journal of Hepatocellular Carcinoma 2022, 9:609-619

Published Date: 18 July 2022

Comparative Response of HCC Cells to TKIs: Modified in vitro Testing and Descriptive Expression Analysis

Sagmeister P, Daza J, Ofner A, Ziesch A, Ye L, Ben Khaled N, Ebert M, Mayerle J, Teufel A, De Toni EN, Munker S

Journal of Hepatocellular Carcinoma 2022, 9:595-607

Published Date: 9 July 2022

Understanding the Role of Metabolic Syndrome as a Risk Factor for Hepatocellular Carcinoma

Chavez-Tapia NC, Murúa-Beltrán Gall S, Ordoñez-Vázquez AL, Nuño-Lambarri N, Vidal-Cevallos P, Uribe M

Journal of Hepatocellular Carcinoma 2022, 9:583-593

Published Date: 5 July 2022

Neoadjuvant Immunotherapy for Hepatocellular Carcinoma

Marron TU, Schwartz M, Corbett V, Merad M

Journal of Hepatocellular Carcinoma 2022, 9:571-581

Published Date: 30 June 2022

Hepatocellular Carcinoma Due to Nonalcoholic Fatty Liver Disease: Current Concepts and Future Challenges

Ahmad MI, Khan MU, Kodali S, Shetty A, Bell SM, Victor D

Journal of Hepatocellular Carcinoma 2022, 9:477-496

Published Date: 1 June 2022

CT-Based Radiomics for the Recurrence Prediction of Hepatocellular Carcinoma After Surgical Resection

Wang F, Chen Q, Zhang Y, Chen Y, Zhu Y, Zhou W, Liang X, Yang Y, Hu H

Journal of Hepatocellular Carcinoma 2022, 9:453-465

Published Date: 23 May 2022

Application of the CT/MRI LI-RADS Treatment Response Algorithm to Contrast-Enhanced Ultrasound: A Feasibility Study

Ruan SM, Cheng MQ, Huang H, Hu HT, Li W, Xie XY, Lu MD, Kuang M, Lin MX, Wang W

Journal of Hepatocellular Carcinoma 2022, 9:437-451

Published Date: 20 May 2022

RNA Binding Motif Protein 3 Promotes Cell Metastasis and Epithelial–Mesenchymal Transition Through STAT3 Signaling Pathway in Hepatocellular Carcinoma

Zhang L, Zhang Y, Shen D, Chen Y, Feng J, Wang X, Ma L, Liao Y, Tang L

Journal of Hepatocellular Carcinoma 2022, 9:405-422

Published Date: 9 May 2022

Identification and Validation of Novel Biomarkers for Hepatocellular Carcinoma, Liver Fibrosis/Cirrhosis and Chronic Hepatitis B via Transcriptome Sequencing Technology

Zhao D, Zhang X, Tang Y, Guo P, Ai R, Hou M, Wang Y, Yuan X, Cui L, Zhang Y, Zhao S, Li W, Wang Y, Sun X, Liu L, Dong S, Li L, Zhao W, Nan Y

Journal of Hepatocellular Carcinoma 2022, 9:389-403

Published Date: 9 May 2022

Macrotrabecular-Massive Hepatocellular Carcinoma: What Should We Know?

Li X, Yao Q, Liu C, Wang J, Zhang H, Li S, Cai P

Journal of Hepatocellular Carcinoma 2022, 9:379-387

Published Date: 5 May 2022

An Overview of Hepatocellular Carcinoma After Insufficient Radiofrequency Ablation

Guo Y, Ren Y, Dong X, Kan X, Zheng C

Journal of Hepatocellular Carcinoma 2022, 9:343-355

Published Date: 26 April 2022

Antiviral Treatments Eliminate the Adverse Impacts of High Baseline HBV Loads on the Survival of HBV-Related HCC Patients

Hu Z, Sun X, Mei J, Hu Z, Yang Z, Hou J, Fu Y, Wang X, Chen M

Journal of Hepatocellular Carcinoma 2022, 9:315-325

Published Date: 19 April 2022

Impact of PNPLA3 p.I148M and Hepatic Steatosis on Long-Term Outcomes for Hepatocellular Carcinoma and HBsAg Seroclearance in Chronic Hepatitis B

Hsueh RC, Wu WJ, Lin CL, Liu CJ, Huang YW, Hu JT, Wu CF, Sung FY, Liu WJ, Yu MW

Journal of Hepatocellular Carcinoma 2022, 9:301-313

Published Date: 11 April 2022

MCT4 Promotes Hepatocellular Carcinoma Progression by Upregulating TRAPPC5 Gene

Niu Z, Yang F, Li H, Wang J, Ni Q, Ma C, Zhu H, Chang H, Zhou X, Lu J, Gao H

Journal of Hepatocellular Carcinoma 2022, 9:289-300

Published Date: 8 April 2022

Autoantibody Against Ferritin Light Chain is a Serum Biomarker for the Detection of Liver Cirrhosis but Not Liver Cancer

Ren P, Wang K, Ma J, Cao X, Zhao J, Zhao C, Guo Y, Ye H

Journal of Hepatocellular Carcinoma 2022, 9:221-232

Published Date: 29 March 2022

LRP1B is a Potential Biomarker for Tumor Immunogenicity and Prognosis of HCC Patients Receiving ICI Treatment

Cheng Y, Tang R, Li X, Wang B, Cheng Y, Xiao S, Sun P, Yu W, Li C, Lin X, Zhu Y

Journal of Hepatocellular Carcinoma 2022, 9:203-220

Published Date: 22 March 2022

Preoperative Radiomics Analysis of Contrast-Enhanced CT for Microvascular Invasion and Prognosis Stratification in Hepatocellular Carcinoma

Xu T, Ren L, Liao M, Zhao B, Wei R, Zhou Z, He Y, Zhang H, Chen D, Chen H, Liao W

Journal of Hepatocellular Carcinoma 2022, 9:189-201

Published Date: 20 March 2022

Borealin Promotes Tumor Growth and Metastasis by Activating the Wnt/β-Catenin Signaling Pathway in Hepatocellular Carcinoma

Chen B, Gu Y, Shen H, Liu Q, Wang H, Li Y, Liu X, Liu Y, Du Q, Sun H, Liao X

Journal of Hepatocellular Carcinoma 2022, 9:171-188

Published Date: 11 March 2022

Regorafenib Combined with PD-1 Blockade Immunotherapy versus Regorafenib as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Study

Huang J, Guo Y, Huang W, Hong X, Quan Y, Lin L, Zhou J, Liang L, Zhang Y, Zhou J, Cai M, Zhu K

Journal of Hepatocellular Carcinoma 2022, 9:157-170

Published Date: 10 March 2022

The Oncogenic and Diagnostic Potential of Stanniocalcin 2 in Hepatocellular Carcinoma

Wu Z, Cheng H, Liu J, Zhang S, Zhang M, Liu F, Li Y, Huang Q, Jiang Y, Chen S, Lv L, Li D, Zeng JZ

Journal of Hepatocellular Carcinoma 2022, 9:141-155

Published Date: 8 March 2022

Postoperative Adjuvant Transarterial Chemoembolization Plus Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma: a Multicentre Retrospective Study

Lin K, Wei F, Huang Q, Lai Z, Zhang J, Chen Q, Jiang Y, Kong J, Tang S, Lin J, Chen Y, Chen J, Zeng Y

Journal of Hepatocellular Carcinoma 2022, 9:127-140

Published Date: 8 March 2022

MicroRNA-128-3p Mediates Lenvatinib Resistance of Hepatocellular Carcinoma Cells by Downregulating c-Met

Xu X, Jiang W, Han P, Zhang J, Tong L, Sun X

Journal of Hepatocellular Carcinoma 2022, 9:113-126

Published Date: 27 February 2022

Current Perspectives on the Unique Roles of Exosomes in Drug Resistance of Hepatocellular Carcinoma

Xue D, Han J, Liang Z, Jia L, Liu Y, Tuo H, Peng Y

Journal of Hepatocellular Carcinoma 2022, 9:99-112

Published Date: 18 February 2022

SLC39A1 Overexpression is Associated with Immune Infiltration in Hepatocellular Carcinoma and Promotes Its Malignant Progression

Ma X, Zhuang H, Wang Q, Yang L, Xie Z, Zhang Z, Tan W, Tang C, Chen Y, Shang C

Journal of Hepatocellular Carcinoma 2022, 9:83-98

Published Date: 15 February 2022

Hepatocellular Carcinoma Risk Prediction in the NIH-AARP Diet and Health Study Cohort: A Machine Learning Approach

Thomas J, Liao LM, Sinha R, Patel T, Antwi SO

Journal of Hepatocellular Carcinoma 2022, 9:69-81

Published Date: 15 February 2022

CtBP1 Mediates Hypoxia-Induced Sarcomatoid Transformation in Hepatocellular Carcinoma

Zhang X, Wang X, Jia L, Yang Y, Yang F, Xiao S

Journal of Hepatocellular Carcinoma 2022, 9:57-67

Published Date: 11 February 2022

Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma

Li Y, Li Y, Zhang J, Ji L, Li M, Sun X, Feng H, Yu Z, Gao Y

Journal of Hepatocellular Carcinoma 2022, 9:41-56

Published Date: 9 February 2022

Dynamic Lymphocyte Changes Following Transarterial Radioembolization: Association with Normal Liver Dose and Effect on Overall Survival

Young S, Ragulojan R, Chen T, Owen J, D'souza D, Sanghvi T, Golzarian J, Flanagan S

Journal of Hepatocellular Carcinoma 2022, 9:29-39

Published Date: 4 February 2022

Factors Associated with Survival of Hepatocellular Carcinoma (HCC) Patients at a Safety Net Hospital in Arizona without On-Site Liver Transplant Program

Turse E, Aboona M, Charley E, Forlemu A, Bowie T, Bhattarai B, Chuang KY, Nadir A

Journal of Hepatocellular Carcinoma 2022, 9:1-11

Published Date: 22 January 2022